BioMolecular Research, Inc.
Drug discovery company names director of business development and research
Published in Law and Health Weekly, August 14th, 2004
Cloudsdale will apply his 20 years of experience in small molecule discovery and management initialing on the new PBMR focused library sets such as GPCR, ion channel blocker & kinase inhibitors plus leading the PBMR expanding lead optimization services. Cloudsdale will head the development of new business opportunities with PBMR's customers, and lead PBMR's business expansion efforts in the custom chemistry area.
He has a broad chemical background ranging from small molecule discovery to early process research. As director of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Biomoda, Inc.
U.S. patent granted for cancer detection method - Cancer Research Technology
License granted to Genentech to patent portfolio of an oncology target - Hagens Berman
Public hospital claims drug manufacturers overcharging disabled and homeless - Health Language, Inc.
Pelosi statement on Medicare prescription drugs price negotiation - HortResearch
Government-funded berryfruit cognitive study needs over-65 volunteers - Legal Issues
Educators Mutual slapped with $2.86 settlement in Medicare fraud - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
